Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00067314
What this trial is testing

Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
Pfizer 65
Early research (Phase 1)Study completedNCT03569280
What this trial is testing

Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients

Who this might be right for
Castration-Resistant Prostate Cancer
Kangpu Biopharmaceuticals, Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT03184090
What this trial is testing

Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC

Who this might be right for
Metastatic Breast Cancer
MedSIR 33
Testing effectiveness (Phase 2)Ended earlyNCT01145508
What this trial is testing

Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Looking for participantsNCT06241846
What this trial is testing

A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
MediLink Therapeutics (Suzhou) Co., Ltd. 100
Not applicableStudy completedNCT07650786
What this trial is testing

Cell Membrane Potential Regulates Spatial-Specific Mechanoptosis Resistance and Metastasis in Colorectal Cancer Via Mechanotransduction and the PVR/CD96 Axis

Who this might be right for
Colorectal Cancer
Ma Tianyi 4
Not applicableUnknownNCT05764941
What this trial is testing

Inetetamab Combined With Pyrotinib and Vinorelbine as First-line to Third-line Treatment for HER2-positive Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
The First Affiliated Hospital with Nanjing Medical University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05700656
What this trial is testing

Galunisertib Combined With Capecitabine in Advanced CRC With PM

Who this might be right for
Colorectal Cancer MetastaticPeritoneal Carcinomatosis
The Netherlands Cancer Institute 31
Testing effectiveness (Phase 2)Study completedNCT01503229
What this trial is testing

Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+1 more
University of Washington 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05383079
What this trial is testing

Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate CancerMCRPCProstate Cancer
Peter MacCallum Cancer Centre, Australia 36
Testing effectiveness (Phase 2)Study completedNCT01336062
What this trial is testing

Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients

Who this might be right for
Gastric Adenocarcinoma
Peking University 19
Testing effectiveness (Phase 2)Study completedNCT01031446
What this trial is testing

Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07592910
What this trial is testing

Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)Prostate Cancer (Adenocarcinoma)
Prostate Cancer Clinical Trials Consortium 60
Testing effectiveness (Phase 2)Ended earlyNCT04918810
What this trial is testing

Biomarker-driven Intermittent Docetaxel in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Castration Resistant Prostatic Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 6
Testing effectiveness (Phase 2)WithdrawnNCT01734681
What this trial is testing

Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer.
GenSpera, Inc.
Not applicableStudy completedNCT04690231
What this trial is testing

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

Who this might be right for
Effect of DrugToxicity, DrugSecondary Resistance
Peking University People's Hospital 79
Testing effectiveness (Phase 2)Study completedNCT03422536
What this trial is testing

Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Basaloid CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+21 more
University of Arizona 78
Early research (Phase 1)Ended earlyNCT05037500
What this trial is testing

Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaStage IV Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8+1 more
Roswell Park Cancer Institute 8
Testing effectiveness (Phase 2)Study completedNCT00831636
What this trial is testing

A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Clavis Pharma 28
Large-scale testing (Phase 3)Not Yet RecruitingNCT06768255
What this trial is testing

Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC

Who this might be right for
Abiraterone AcetateMCRPC (metastatic Castration-resistant Prostate Cancer)
Ding-Wei Ye 400
Next Page